4//SEC Filing
Pellegrini Niamh Louise 4
Accession 0001567619-21-006242
CIK 0001444380other
Filed
Mar 11, 7:00 PM ET
Accepted
Mar 12, 5:45 PM ET
Size
8.8 KB
Accession
0001567619-21-006242
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Pellegrini Niamh Louise
Chief Commercial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-10−750→ 65,575 totalExercise: $64.95Exp: 2029-07-14→ Common Stock (750 underlying) - Sale
Common Stock
2021-03-10$148.08/sh−750$111,060→ 39,218 total - Exercise/Conversion
Common Stock
2021-03-10$64.95/sh+750$48,713→ 39,968 total
Footnotes (3)
- [F1]Includes 38,563 restricted stock units.
- [F2]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from July 15, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001620611
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 7:00 PM ET
- Accepted
- Mar 12, 5:45 PM ET
- Size
- 8.8 KB